contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls {
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


monsenso-issues-warrants-to-the-deputy-chairman-of-the-board

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

alternatePageUrls

imgUrl

description

Monsenso operates in the IT sector. The company specializes in the provision of digital follow-up systems for care and nursing, as well as hospitals. The solutions are software-based and are mainly used for monitoring patients' health, as well as for internal monitoring and analysis. The largest operations are in the Nordic market. The head office is located in Copenhagen.

Monsenso

14.5.2024 08:45:00 CEST | Monsenso | Company AnnouncementCompany announcement no. 12-2024Copenhagen, 2024.05.14This message includes inside information. The Board of Directors of Monsenso announces...

14.5.2024 08:45:00 CEST | Monsenso | Company AnnouncementCompany announcement no. 12-2024Copenhagen, 2024.05.14This message includes inside information. The Board of Directors of Monsenso announces the decision to issue warrants to the deputy chairman of the board Kasper R Kristiansen, following § 5.3 of the articles of association.The vesting period for the warrants is 36 months from 1 May 2024 to 30 April 2027, but only if the recipient is still a board member. Unexercised warrants expire on 31 August 2031. DKK 1,662,616 warrants have been granted, giving the right to subscribe for a nominal DKK 166,261.60 shares in the company.The Board of Directors has set the exercise price at DKK 0.35 per warrant, corresponding to the market rate calculated as a 90-day closing price and following § 5.3 of the company's articles of association. The closing price on May 10, 2024, was DKK 0.42 per share.The warrant holder shall not pay any compensation for granting the warrants. The vested warrants can be exercised twice a year after publication of the company's annual and half-yearly report in a utilization window of currently 2 weeks.Kasper R. Kristiansen is awarded the above warrants as remuneration for his work in developing a business model for the company with growth and profitability in mind.According to “Black &amp; Scholes”, the value of the entire Warrant program can be calculated at TDKK 236 or TDKK 79 p.a. for 3 years and is in line with the company's remuneration policy.Monsenso's share capital amounts to a nominal value of DKK 6,650,462.90 divided into 66,504,629 shares of DKK 0.10.Any inquiries regarding this notice should be directed to:MonsensoCEO Thomas Lethenborg Tel. +45 21 29 88 27 E-mail:&nbsp;<a href="mailto:lethenborg@monsenso.com">lethenborg@monsenso.com</a>&nbsp;Chairman of the board Peter Mørch Eriksen E-mail:&nbsp;<a href="mailto:Petermorcheriksen@outlook.com">Petermorcheriksen@outlook.com</a>Certified AdviserNorden CEF A/S John NordenE-mail:&nbsp;<a href="mailto:jn@nordencef.dk">jn@nordencef.dk</a><h4>About Monsenso</h4>Monsenso is an innovative technology company offering a digital health solution used for decentralised trials, remote patient monitoring and treatment support. Our mission is to contribute to improved health for more people at lower costs by supporting treatment digitally and leveraging patient-reported outcomes data. Our solution helps optimise the treatment and gives a detailed overview of an individual’s health through the collection of outcome, adherence and behavioral data. It connects individuals, carers and health care providers to enable personalised treatment, remote care and early intervention. We collaborate with health and social care, pharmaceuticals and leading researcher worldwide in our endeavors to deliver solutions that fit into the lives of patients and health care professionals. To learn more visit <a href="http://www.monsenso.com">www.monsenso.com</a><h4>Attachments</h4><ul> <li> <a href="https://via.ritzau.dk/ir-files/13559904/8590/13364/Download%20announcement%20as%20PDF.pdf">Download announcement as PDF.pdf</a> </li></ul>

Monsenso issues warrants to the deputy chairman of the board

Probabilities of success in drug development

Drug development investment: Value creation through M&As and licensing agreements

Valuation methods: Valuation multiples

Return on capital (ROE, ROI, ROIC, RONIC)

Helsinki Stock Exchange is cheap

About Monsenso

Attachments

Stay up to date with our newsletter